News
Arvinas noted that vepdegestrant, which is being developed alongside Pfizer to treat certain types of advanced or metastatic breast cancer, was generally well tolerated in the clinical trial, and that ...
16h
MedPage Today on MSNAlternative Endpoints in Phase III Trials Don't Always Mean Boosts to OS, QOLThe findings suggest that "the heightened focus on alternative endpoints, now representing the most common primary endpoint, ...
The economic cost of obtaining a degree is increasing, as the number of high-paying jobs you can access without one falls.
Love in later life can be a wonderful thing—a second (or third!) chance at companionship, laughter, and maybe even a little ...
This week ministers admitted that the country could run out of drinking water within 10 years as they unveiled plans to fast-track the building of two new reservoirs.
The graphic design platform registered 666 million designs in India in 2024. Canva India's creative lead breaks down the ...
1h
Daily Maverick on MSNInside the mind of a monster — understanding the psychology of child abusersWith more than 13,000 child abuse crimes reported in 2023/24, experts warn that perpetrators often hide in plain sight as ...
As the NHS looks towards the future with hope of improvement and efficiency, the workforce will be central to this.
Rigorous study design and analytical standards are required to generate reliable findings in healthcare from artificial intelligence (AI) research. One crucial but often overlooked aspect is the ...
ASCO heard data suggesting that cell therapy may be a way of treating glioblastoma, which has been long seen as incurable.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results